Published in World J Gastroenterol on December 07, 2014
Validation of chemical compound library screening for transcriptional co-activator with PDZ-binding motif inhibitors using GFP-fused transcriptional co-activator with PDZ-binding motif. Cancer Sci (2016) 0.75
Identification of drugs that restore primary cilium expression in cancer cells. Oncotarget (2016) 0.75
Loss of tricellular tight junction protein LSR promotes cell invasion and migration via upregulation of TEAD1/AREG in human endometrial cancer. Sci Rep (2017) 0.75
Cancer statistics, 2012. CA Cancer J Clin (2012) 87.38
Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell (2006) 12.72
Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon. Proc Natl Acad Sci U S A (2006) 8.01
Hippo signaling in organ size control. Genes Dev (2007) 6.29
From cell structure to transcription: Hippo forges a new path. Cell (2006) 4.65
Expression of Yes-associated protein in common solid tumors. Hum Pathol (2008) 4.61
The emerging role of the hippo pathway in cell contact inhibition, organ size control, and cancer development in mammals. Cancer Cell (2008) 4.08
The Hippo-YAP pathway: new connections between regulation of organ size and cancer. Curr Opin Cell Biol (2008) 3.63
PML, YAP, and p73 are components of a proapoptotic autoregulatory feedback loop. Mol Cell (2008) 2.66
How will HPV vaccines affect cervical cancer? Nat Rev Cancer (2006) 2.23
Yes-associated protein (YAP) functions as a tumor suppressor in breast. Cell Death Differ (2008) 2.03
A cell-based assay to screen stimulators of the Hippo pathway reveals the inhibitory effect of dobutamine on the YAP-dependent gene transcription. J Biochem (2011) 2.00
Human papillomavirus type specific DNA and RNA persistence--implications for cervical disease progression and monitoring. J Med Virol (2004) 1.69
Functional complexes between YAP2 and ZO-2 are PDZ domain-dependent, and regulate YAP2 nuclear localization and signalling. Biochem J (2010) 1.34
Mechanisms of chemotherapeutic drug resistance in cancer therapy--a quick review. Taiwan J Obstet Gynecol (2009) 1.26
A cross-sectional study of a prototype carcinogenic human papillomavirus E6/E7 messenger RNA assay for detection of cervical precancer and cancer. Clin Cancer Res (2007) 1.17
The pharmacology of dobutamine. Am J Med Sci (1987) 1.10
Human papillomavirus E6/E7 mRNA expression in women younger than 30 years of age. Gynecol Oncol (2005) 1.06
Significance and relationship between Yes-associated protein and survivin expression in gastric carcinoma and precancerous lesions. World J Gastroenterol (2009) 0.95
Inhibition of Aβ(25-35)-induced cell apoptosis by low-power-laser-irradiation (LPLI) through promoting Akt-dependent YAP cytoplasmic translocation. Cell Signal (2011) 0.94
PLCγ is required for RhoGDI2-mediated cisplatin resistance in gastric cancer. Biochem Biophys Res Commun (2011) 0.91
RNA interference mediated YAP gene silencing inhibits invasion and metastasis of human gastric cancer cell line SGC-7901. Hepatogastroenterology (2012) 0.88
Safety and observer variability of cardiac magnetic resonance imaging combined with low-dose dobutamine stress-testing in patients with complex congenital heart disease. Int J Cardiol (2009) 0.81
[Dobutamine: mechanisms of action and use in acute cardiovascular pathology]. Ann Cardiol Angeiol (Paris) (1991) 0.79